Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on: May 31,2024 8

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on:May 31,2024 8

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head

Updated on: May 31,2024 6

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head

Updated on:May 31,2024 6

Study shows importance of quality of life scores as prognostic factors in cancer patients

by European Organisation for Research and Treatment of Cancer (EORTC)Credit: CC0 Public DomainCancer patients own reporting of their quality of life can be important in predicting the outcome of their

Updated on: May 31,2024 7

Study shows importance of quality of life scores as prognostic factors in cancer patients

by European Organisation for Research and Treatment of Cancer (EORTC)Credit: CC0 Public DomainCancer patients own reporting of their quality of life can be important in predicting the outcome of their

Updated on:May 31,2024 7

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on: May 31,2024 5

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on:May 31,2024 5

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Updated on: May 29,2024 0

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Updated on:May 29,2024 0

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on: May 29,2024 0

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on:May 29,2024 0

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on: May 28,2024 7

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on:May 28,2024 7

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi

Updated on: May 27,2024 4

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi

Updated on:May 27,2024 4

Research team identifies a potential strategy in fight against brain cancer

by Virginia TechA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists with the Virginia Tech Carilion Research I

Updated on: May 27,2024 3

Research team identifies a potential strategy in fight against brain cancer

by Virginia TechA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists with the Virginia Tech Carilion Research I

Updated on:May 27,2024 3

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj

Updated on: May 27,2024 8

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj

Updated on:May 27,2024 8

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Updated on: May 27,2024 3

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Updated on:May 27,2024 3

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a

Updated on: May 27,2024 4

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a

Updated on:May 27,2024 4